Literature DB >> 15655046

Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response.

Y Chen1, H Wei, B Gao, Z Hu, S Zheng, Z Tian.   

Abstract

Natural killer (NK) cells are abundant in the normal liver, accounting for around one-third of intrahepatic lymphocytes and are important in the defence against hepatitis B virus (HBV) infection as innate immune responses. In this review, we discuss the mechanisms of hepatic NK cell activity against HBV. Whether directly activated by HBV infection or indirectly activated by other lymphocytes such as NKT cells or antigen-presenting cells (APCs), hepatic NK cells exert their anti-viral functions by natural cytotoxicity and production of high levels of cytokines. However, activated NK cells play an important role in regulating adaptive immune responses by interaction with other lymphocytes such as T, B and APCs. In addition, NK cells may contribute to the lymphocyte-mediated liver injury during HBV infection that was previously considered to be mediated only by CD8+ T cells or/and NKT cells.

Entities:  

Mesh:

Year:  2005        PMID: 15655046     DOI: 10.1111/j.1365-2893.2005.00543.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  19 in total

1.  Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity.

Authors:  Philipp A Lang; Karl S Lang; Haifeng C Xu; Melanie Grusdat; Ian A Parish; Mike Recher; Alisha R Elford; Salim Dhanji; Namir Shaabani; Charles W Tran; Dilan Dissanayake; Ramtin Rahbar; Magar Ghazarian; Anne Brüstle; Jason Fine; Peter Chen; Casey T Weaver; Christoph Klose; Andreas Diefenbach; Dieter Häussinger; James R Carlyle; Susan M Kaech; Tak W Mak; Pamela S Ohashi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-13       Impact factor: 11.205

Review 2.  NK cell trafficking in health and autoimmunity:a comprehensive review.

Authors:  Hui Peng; Zhigang Tian
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

3.  KIR : HLA association with clinical manifestations of HBV infection in Madurai, south India.

Authors:  Narayanan Kalyanaraman; Lakshmikanthan Thayumanavan; Mariakuttikan Jayalakshmi
Journal:  J Genet       Date:  2016-03       Impact factor: 1.166

4.  The impact of KIR-HLA genotype on hepatitis B virus clearance in Iranian infected individuals.

Authors:  Alireza Shah-Hosseini; Mohammad Jafari; Asadollah Mohammadi; Roozbeh Sanaei; Seyed Moayed Alavian; Amin Doosti-Irani; Mehrnoush Nooradeh Keykavousi; Nader Tajik
Journal:  Med Microbiol Immunol       Date:  2017-10-14       Impact factor: 3.402

Review 5.  Cell mediators of autoimmune hepatitis and their therapeutic implications.

Authors:  Aldo J Montano-Loza; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2014-12-09       Impact factor: 3.199

6.  Mutations to bid cleavage sites protect hepatocytes from apoptosis after ischemia/reperfusion injury.

Authors:  Erica Riddle-Taylor; Kazuhito Nagasaki; Joseph Lopez; Carlos O Esquivel; Olivia M Martinez; Sheri M Krams
Journal:  Transplantation       Date:  2007-09-27       Impact factor: 4.939

7.  CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis.

Authors:  Maureen N Ajuebor; Zenebech Wondimu; Cory M Hogaboam; Tai Le; Amanda E I Proudfoot; Mark G Swain
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

Review 8.  Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases.

Authors:  Bin Gao; Svetlana Radaeva; Ogyi Park
Journal:  J Leukoc Biol       Date:  2009-09       Impact factor: 4.962

9.  Activation mechanisms of natural killer cells during influenza virus infection.

Authors:  Ilwoong Hwang; Jeannine M Scott; Tejaswi Kakarla; David M Duriancik; Seohyun Choi; Chunghwan Cho; Taehyung Lee; Hyojin Park; Anthony R French; Eleni Beli; Elizabeth Gardner; Sungjin Kim
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

10.  Pathological role of interleukin-17 in poly I:C-induced hepatitis.

Authors:  Jianqin He; Guanjing Lang; Shiping Ding; Lanjuan Li
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.